J. Buyniski

发表

The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.

J. Fleming, J. Buchanan, J. Buyniski, 1976, European journal of pharmacology.

The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.

J. Buyniski, M. Bierwagen, A. Pircio, 1976, Archives internationales de pharmacodynamie et de therapie.

Effects of tiodazosin, praxosin, trimazosin and phentolamine on blood pressure, heart rate and on pre- and postsynaptic alpha-adrenergic receptors in the rat.

J. Buyniski, J. Campbell, J. Schurig, 1980, Clinical and experimental hypertension.

A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

J. Buyniski, R. L. Cavanagh, J. Usakewicz, 1983, The Journal of pharmacology and experimental therapeutics.

Cerebral Vascular Responses to Changes in the Ionic Osmolar Composition of Blood

J. Buyniski, C. E. Rapela, 1969 .

A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A).

J. Fleming, J. Buyniski, 1979, Thrombosis research.

Cerebral and renal vascular smooth muscle responses to adenosine.

J. Buyniski, C. E. Rapela, 1969, The American journal of physiology.

Isosteric replacement in a series of β-substituted monophosphonate calcium antagonists

J. G. Sarmiento, M. Foley, J. Buyniski, 1993 .

Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.

J. Buyniski, M. Bierwagen, R. Gardier, 1972, The Journal of pharmacology and experimental therapeutics.

Possible mechanism for the fibrinolytic effect of certain bis-tetrahydroisquinolines: evidence for histamine release.

J. Buyniski, H. Imanishi, R. L. Cavanagh, 1974, Thrombosis research.

Potential non-dopaminergic gastrointestinal prokinetic agents in the series of substituted benzamides

J. Buyniski, I. Monković, D. Willner, 1989 .

Swallow-evoked peristalsis in opossum esophagus: role of cholinergic mechanisms.

J. Gidda, J. Buyniski, 1986, The American journal of physiology.

Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.

J. Buyniski, J. Schurig, R. L. Cavanagh, 1978, Archives internationales de pharmacodynamie et de therapie.

Pharmacological effects of a combination of butorphanol and acetaminophen.

J. Buyniski, A. Pircio, L. E. Roebel, 1978, Archives internationales de pharmacodynamie et de therapie.

Formed Elements of the Blood Platelets, and Thrombosis

F. Mckenzie, M. Debakey, D. Stasiw, 1976 .

Effect of BMY‐25368, a potent and long‐acting histamine H2‐receptor antagonist, on gastric secretion and aspirin‐induced gastric lesions in the dog

J. Buyniski, R. L. Cavanagh, 1989, Alimentary pharmacology & therapeutics.

Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats.

H. Tilson, J. Buyniski, J. Gylys, 1977, European journal of pharmacology.

BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.

J. Buyniski, J. Gylys, R. N. Wright, 1988, The Journal of pharmacology and experimental therapeutics.

Comparative gastrointestinal and biliary tract effects of morphine and butorphanol (Stadol).

J. Buyniski, R. L. Cavanagh, L. E. Roebel, 1979, Journal of medicine.

Enhanced platelet aggregability in dogs following myocardial infarction.

J. Fleming, J. Buyniski, 1977, Life sciences.

DURATION OF ACTION OF NEW H2-BLOCKERS

J. Buyniski, P. Müller, B. Simon, 1984, The Lancet.